| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Metagenome | 5 | 2017 | 268 | 2.01 | Why? |
| Metagenomics | 6 | 2021 | 823 | 1.54 | Why? |
| Sequence Analysis, DNA | 8 | 2017 | 2830 | 1.22 | Why? |
| Microbiota | 5 | 2021 | 1240 | 0.92 | Why? |
| Environmental Microbiology | 2 | 2017 | 575 | 0.92 | Why? |
| High-Throughput Nucleotide Sequencing | 11 | 2021 | 3633 | 0.87 | Why? |
| Contig Mapping | 1 | 2017 | 5 | 0.73 | Why? |
| Microbial Consortia | 1 | 2017 | 20 | 0.71 | Why? |
| DNA Barcoding, Taxonomic | 1 | 2017 | 39 | 0.69 | Why? |
| Ambulances | 1 | 2017 | 287 | 0.56 | Why? |
| Benchmarking | 1 | 2017 | 627 | 0.51 | Why? |
| DNA Methylation | 4 | 2019 | 688 | 0.44 | Why? |
| Molecular Sequence Annotation | 1 | 2013 | 478 | 0.43 | Why? |
| Gene Expression Profiling | 4 | 2021 | 3788 | 0.42 | Why? |
| Bacteria | 2 | 2017 | 1897 | 0.39 | Why? |
| Software | 2 | 2017 | 2501 | 0.37 | Why? |
| Reference Standards | 3 | 2017 | 1163 | 0.37 | Why? |
| Meiosis | 2 | 2018 | 12 | 0.37 | Why? |
| Gene Library | 3 | 2021 | 234 | 0.37 | Why? |
| Germ Cells | 2 | 2018 | 39 | 0.35 | Why? |
| Genome, Bacterial | 3 | 2018 | 446 | 0.30 | Why? |
| DNA, Bacterial | 3 | 2017 | 835 | 0.27 | Why? |
| Adenosine | 2 | 2018 | 509 | 0.26 | Why? |
| Public Health Surveillance | 1 | 2017 | 3129 | 0.25 | Why? |
| Genome | 2 | 2018 | 341 | 0.25 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.23 | Why? |
| DNA | 2 | 2017 | 778 | 0.22 | Why? |
| Arginine Vasopressin | 1 | 2019 | 14 | 0.21 | Why? |
| Leukemia, Myeloid, Acute | 2 | 2017 | 676 | 0.21 | Why? |
| Astronauts | 1 | 2019 | 10 | 0.20 | Why? |
| Enterobacter | 1 | 2018 | 18 | 0.20 | Why? |
| Spacecraft | 1 | 2018 | 21 | 0.19 | Why? |
| RNA | 2 | 2017 | 1278 | 0.19 | Why? |
| Awards and Prizes | 1 | 2020 | 101 | 0.19 | Why? |
| Space Flight | 1 | 2019 | 37 | 0.19 | Why? |
| Shock, Hemorrhagic | 1 | 2019 | 81 | 0.19 | Why? |
| Cercocebus atys | 1 | 2018 | 5 | 0.19 | Why? |
| Epigenetic Repression | 1 | 2017 | 5 | 0.18 | Why? |
| Transcriptome | 5 | 2021 | 3466 | 0.18 | Why? |
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2017 | 20 | 0.18 | Why? |
| Rhabdoid Tumor | 1 | 2017 | 2 | 0.18 | Why? |
| Genetic Variation | 3 | 2021 | 3919 | 0.18 | Why? |
| Hemostatics | 1 | 2019 | 142 | 0.18 | Why? |
| Transposases | 1 | 2017 | 30 | 0.18 | Why? |
| Extreme Environments | 1 | 2017 | 10 | 0.17 | Why? |
| Tryptamines | 1 | 2017 | 29 | 0.17 | Why? |
| Isocitrate Dehydrogenase | 1 | 2017 | 33 | 0.17 | Why? |
| Photoperiod | 1 | 2017 | 41 | 0.17 | Why? |
| Macular Degeneration | 1 | 2020 | 194 | 0.17 | Why? |
| RNA, Bacterial | 1 | 2017 | 116 | 0.16 | Why? |
| RNA Stability | 1 | 2018 | 285 | 0.16 | Why? |
| Base Composition | 1 | 2017 | 203 | 0.16 | Why? |
| Algorithms | 2 | 2014 | 7346 | 0.16 | Why? |
| Bone Marrow Cells | 1 | 2017 | 186 | 0.16 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 343 | 0.16 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.15 | Why? |
| Adaptation, Physiological | 1 | 2019 | 359 | 0.15 | Why? |
| Genomics | 4 | 2018 | 3118 | 0.15 | Why? |
| Cell Cycle Proteins | 1 | 2018 | 297 | 0.15 | Why? |
| Phalaris | 1 | 2014 | 1 | 0.15 | Why? |
| Molecular Typing | 1 | 2017 | 280 | 0.15 | Why? |
| Simian Immunodeficiency Virus | 1 | 2018 | 251 | 0.15 | Why? |
| Water Microbiology | 1 | 2017 | 248 | 0.14 | Why? |
| HLA Antigens | 1 | 2021 | 830 | 0.14 | Why? |
| Nucleic Acid Conformation | 1 | 2018 | 621 | 0.14 | Why? |
| Genome, Viral | 3 | 2021 | 13157 | 0.14 | Why? |
| RNA Helicases | 1 | 2018 | 413 | 0.14 | Why? |
| Proto-Oncogene Proteins | 1 | 2017 | 340 | 0.14 | Why? |
| Blood Component Transfusion | 1 | 2019 | 740 | 0.14 | Why? |
| Biotechnology | 1 | 2017 | 444 | 0.14 | Why? |
| Societies, Scientific | 1 | 2017 | 414 | 0.14 | Why? |
| Molecular Diagnostic Techniques | 3 | 2021 | 4239 | 0.13 | Why? |
| RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.13 | Why? |
| Quality Control | 1 | 2017 | 628 | 0.13 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.13 | Why? |
| Biodiversity | 1 | 2017 | 546 | 0.13 | Why? |
| Complement Activation | 1 | 2020 | 949 | 0.13 | Why? |
| Drug Interactions | 1 | 2021 | 1653 | 0.13 | Why? |
| Exome | 1 | 2014 | 207 | 0.13 | Why? |
| Host Specificity | 1 | 2018 | 926 | 0.12 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.12 | Why? |
| Gene Expression Regulation, Viral | 1 | 2018 | 925 | 0.12 | Why? |
| Epigenomics | 1 | 2013 | 139 | 0.12 | Why? |
| CpG Islands | 1 | 2013 | 230 | 0.12 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.11 | Why? |
| Methyltransferases | 1 | 2017 | 720 | 0.11 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2018 | 533 | 0.11 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.11 | Why? |
| Circadian Rhythm | 1 | 2017 | 607 | 0.11 | Why? |
| Hepatitis B virus | 1 | 2018 | 882 | 0.11 | Why? |
| Single-Cell Analysis | 1 | 2021 | 2450 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Stress, Physiological | 1 | 2014 | 378 | 0.10 | Why? |
| New York City | 2 | 2021 | 7432 | 0.10 | Why? |
| Nucleic Acid Amplification Techniques | 2 | 2021 | 3388 | 0.10 | Why? |
| Databases, Genetic | 1 | 2015 | 1127 | 0.09 | Why? |
| Leukemia | 1 | 2013 | 598 | 0.09 | Why? |
| Hemorrhage | 1 | 2020 | 3013 | 0.09 | Why? |
| Medical Informatics | 1 | 2015 | 648 | 0.09 | Why? |
| Molecular Targeted Therapy | 1 | 2017 | 1579 | 0.09 | Why? |
| Humans | 28 | 2021 | 930598 | 0.08 | Why? |
| Thrombocytopenia | 1 | 2020 | 2093 | 0.08 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.08 | Why? |
| Wounds and Injuries | 1 | 2019 | 1708 | 0.08 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.08 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.07 | Why? |
| Computational Biology | 2 | 2017 | 4514 | 0.07 | Why? |
| Phylogeny | 3 | 2018 | 13341 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.07 | Why? |
| Models, Biological | 1 | 2021 | 4907 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.06 | Why? |
| Animals | 8 | 2018 | 78931 | 0.06 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.06 | Why? |
| United States National Aeronautics and Space Administration | 1 | 2019 | 36 | 0.05 | Why? |
| Telomere Homeostasis | 1 | 2019 | 52 | 0.05 | Why? |
| Genomic Instability | 1 | 2019 | 80 | 0.05 | Why? |
| United States | 4 | 2021 | 46150 | 0.05 | Why? |
| DNA Breaks, Double-Stranded | 1 | 2017 | 17 | 0.04 | Why? |
| Biota | 1 | 2017 | 19 | 0.04 | Why? |
| Chromosome Breakpoints | 1 | 2017 | 3 | 0.04 | Why? |
| DNA End-Joining Repair | 1 | 2017 | 4 | 0.04 | Why? |
| Arylalkylamine N-Acetyltransferase | 1 | 2017 | 2 | 0.04 | Why? |
| Terminal Repeat Sequences | 1 | 2017 | 13 | 0.04 | Why? |
| Polyproteins | 1 | 2021 | 814 | 0.04 | Why? |
| Carotid Intima-Media Thickness | 1 | 2019 | 179 | 0.04 | Why? |
| Macrolides | 1 | 2021 | 369 | 0.04 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Retroelements | 1 | 2017 | 27 | 0.04 | Why? |
| Pineal Gland | 1 | 2017 | 37 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2018 | 264 | 0.04 | Why? |
| Mice, Mutant Strains | 1 | 2017 | 42 | 0.04 | Why? |
| Frameshift Mutation | 1 | 2018 | 158 | 0.04 | Why? |
| Tumor Cells, Cultured | 1 | 2017 | 254 | 0.04 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.04 | Why? |
| fms-Like Tyrosine Kinase 3 | 1 | 2017 | 43 | 0.04 | Why? |
| Exons | 1 | 2018 | 158 | 0.04 | Why? |
| Genes, Tumor Suppressor | 1 | 2017 | 43 | 0.04 | Why? |
| DNA, Neoplasm | 1 | 2017 | 56 | 0.04 | Why? |
| Mice | 4 | 2018 | 21357 | 0.04 | Why? |
| Azacitidine | 1 | 2017 | 42 | 0.04 | Why? |
| Gene Rearrangement | 1 | 2017 | 84 | 0.04 | Why? |
| Dioxygenases | 1 | 2017 | 40 | 0.04 | Why? |
| DNA Repair | 1 | 2017 | 114 | 0.04 | Why? |
| Chromosome Aberrations | 1 | 2017 | 54 | 0.04 | Why? |
| Carotid Arteries | 1 | 2019 | 182 | 0.04 | Why? |
| Hep G2 Cells | 1 | 2018 | 391 | 0.04 | Why? |
| Chromosome Mapping | 1 | 2017 | 178 | 0.04 | Why? |
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 95 | 0.04 | Why? |
| Whole Genome Sequencing | 2 | 2018 | 3239 | 0.04 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.04 | Why? |
| DNA Damage | 1 | 2019 | 285 | 0.04 | Why? |
| Cell Surface Display Techniques | 1 | 2017 | 170 | 0.04 | Why? |
| RNA Processing, Post-Transcriptional | 1 | 2017 | 110 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| DNA Primers | 1 | 2021 | 1170 | 0.04 | Why? |
| Simian Acquired Immunodeficiency Syndrome | 1 | 2018 | 154 | 0.04 | Why? |
| Macaca | 1 | 2018 | 388 | 0.04 | Why? |
| Mutagenesis, Site-Directed | 1 | 2017 | 449 | 0.04 | Why? |
| Aminopyridines | 1 | 2017 | 121 | 0.04 | Why? |
| Amino Acid Sequence | 2 | 2018 | 6049 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Reverse Transcription | 1 | 2018 | 673 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Triazines | 1 | 2017 | 246 | 0.03 | Why? |
| Cell Adhesion Molecules | 1 | 2018 | 472 | 0.03 | Why? |
| Gene Expression Regulation, Plant | 1 | 2014 | 110 | 0.03 | Why? |
| Toll-Like Receptor 4 | 1 | 2018 | 390 | 0.03 | Why? |
| Infertility | 1 | 2018 | 247 | 0.03 | Why? |
| Genetic Testing | 1 | 2018 | 395 | 0.03 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.03 | Why? |
| RNA Interference | 1 | 2017 | 534 | 0.03 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Sequence Deletion | 1 | 2018 | 674 | 0.03 | Why? |
| Male | 8 | 2021 | 367725 | 0.03 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.03 | Why? |
| Alveolar Epithelial Cells | 1 | 2021 | 1445 | 0.03 | Why? |
| Body Weight | 1 | 2019 | 1074 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2021 | 1439 | 0.03 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2017 | 624 | 0.03 | Why? |
| Viral Tropism | 1 | 2021 | 1329 | 0.03 | Why? |
| Infertility, Male | 1 | 2017 | 322 | 0.03 | Why? |
| Retina | 1 | 2017 | 424 | 0.03 | Why? |
| Mutation, Missense | 1 | 2018 | 863 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Drug Resistance, Bacterial | 1 | 2021 | 1414 | 0.03 | Why? |
| Decontamination | 1 | 2021 | 1196 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| Tandem Mass Spectrometry | 1 | 2017 | 1031 | 0.03 | Why? |
| Viral Proteins | 2 | 2021 | 7370 | 0.03 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.03 | Why? |
| HIV | 1 | 2018 | 1116 | 0.03 | Why? |
| Trauma Centers | 1 | 2019 | 1195 | 0.03 | Why? |
| Epigenesis, Genetic | 1 | 2017 | 711 | 0.03 | Why? |
| Catalytic Domain | 1 | 2017 | 1757 | 0.03 | Why? |
| Waste Water | 1 | 2021 | 2185 | 0.03 | Why? |
| Adult | 4 | 2021 | 244371 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2017 | 1276 | 0.03 | Why? |
| Melatonin | 1 | 2017 | 578 | 0.03 | Why? |
| Gene Expression | 1 | 2020 | 3332 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Aged | 3 | 2021 | 215776 | 0.02 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.02 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Female | 5 | 2021 | 380317 | 0.02 | Why? |
| Macrophages | 1 | 2021 | 2784 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Double-Blind Method | 1 | 2019 | 5988 | 0.02 | Why? |
| Clinical Protocols | 1 | 2019 | 2734 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.02 | Why? |
| Anti-Bacterial Agents | 2 | 2021 | 10083 | 0.02 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2021 | 3607 | 0.02 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2019 | 2585 | 0.02 | Why? |
| Macaca mulatta | 1 | 2017 | 3716 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.02 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Protein Conformation | 1 | 2017 | 4386 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Gastrointestinal Microbiome | 1 | 2019 | 1961 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.02 | Why? |
| Neutrophils | 1 | 2021 | 5476 | 0.02 | Why? |
| Phenotype | 1 | 2014 | 4037 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Laboratories | 1 | 2015 | 2858 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Adolescent | 1 | 2019 | 86841 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Young Adult | 1 | 2019 | 93724 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |